Argenica Therapeutics' Phase 2 stroke drug trial hits major milestone

By Proactive Investors / November 06, 2024 / www.youtube.com / Article Link


Argenica Therapeutics Ltd (ASX:AGN, OTC:OTCMKTS: AGNTF) CEO and managing director, Dr Liz Dallimore talked with ...

Recent News

Largest gold producers see strong Q3/25 earnings
November 17, 2025 / www.canadianminingreport.com

Gold stocks jump on gain in metal price
November 17, 2025 / www.canadianminingreport.com

AOCE and WB boost gold targets for 2025 significantly
November 10, 2025 / www.canadianminingreport.com

Gold and silver price ETFs see major net outflows
November 04, 2025 / canadianminingreport.com

Gold stocks decline by less than metal price
November 04, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok